SPRINGWORKS THERAPEUTICS, INC. Operating Expenses
SPRINGWORKS THERAPEUTICS, INC. reported Operating Expenses of $84.00 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-11-02
- SPRINGWORKS THERAPEUTICS, INC. operating expenses for the quarter ending 2023-09-30 was $84.00M, a 17.09% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. operating expenses for the quarter ending 2023-06-30 was $82.85M, a 20.06% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. operating expenses for the quarter ending 2023-03-31 was $77.70M, a 26.40% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. operating expenses for the quarter ending 2022-12-31 was $78.45M, a 40.61% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. operating expenses for fiscal 2022 was $280.67M, a 61.80% increase from fiscal 2021.
- SPRINGWORKS THERAPEUTICS, INC. operating expenses for fiscal 2021 was $173.47M, a 113.30% increase from fiscal 2020.
- SPRINGWORKS THERAPEUTICS, INC. operating expenses for fiscal 2020 was $81.32M, a 37.28% increase from fiscal 2019.
- SPRINGWORKS THERAPEUTICS, INC. operating expenses for fiscal 2019 was $59.24M, a 220.37% increase from fiscal 2018.
| Period end | Operating Expenses 3 month | Operating Expenses 4 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $84.00M 10-Q · filed 2023-11-02 | $166.85M derived: sum of 2 quarters · filed 2023-11-02 | $244.55M 10-Q · filed 2023-11-02 | $323.00M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2023-06-30 | $82.85M 10-Q · filed 2023-08-02 | $160.55M 10-Q · filed 2023-08-02 | $239.00M derived: sum of 3 quarters · filed 2023-08-02 | $310.75M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2023-03-31 | $77.70M 10-Q · filed 2023-05-03 | $156.15M derived: sum of 2 quarters · filed 2023-05-03 | $227.89M derived: sum of 3 quarters · filed 2023-11-02 | $296.90M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-12-31 | $78.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $150.19M derived: sum of 2 quarters · filed 2023-11-02 | $219.21M derived: sum of 3 quarters · filed 2023-11-02 | $280.67M 10-K · filed 2023-02-28 | |
| 2022-09-30 | $71.74M 10-Q · filed 2023-11-02 | $140.75M derived: sum of 2 quarters · filed 2023-11-02 | $202.22M 10-Q · filed 2023-11-02 | $258.02M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | $69.01M 10-Q · filed 2023-08-02 | $130.48M 10-Q · filed 2023-08-02 | $186.28M derived: sum of 3 quarters · filed 2023-08-02 | $227.17M derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-03-31 | $61.47M 10-Q · filed 2023-05-03 | $117.27M derived: sum of 2 quarters · filed 2023-05-03 | $158.16M derived: sum of 3 quarters · filed 2023-05-03 | $205.18M derived: sum of 4 quarters · filed 2023-05-03 | |
| 2021-12-31 | $55.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $96.69M derived: sum of 2 quarters · filed 2023-02-28 | $143.71M derived: sum of 3 quarters · filed 2023-02-28 | $173.47M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $40.90M 10-Q · filed 2022-11-03 | $87.92M derived: sum of 2 quarters · filed 2022-11-03 | $117.67M 10-Q · filed 2022-11-03 | $141.45M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $47.02M 10-Q · filed 2022-08-04 | $76.78M 10-Q · filed 2022-08-04 | $100.56M derived: sum of 3 quarters · filed 2023-02-28 | $122.15M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $29.76M 10-Q · filed 2022-05-05 | $53.54M derived: sum of 2 quarters · filed 2023-02-28 | $75.13M derived: sum of 3 quarters · filed 2023-02-28 | $94.95M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $23.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $45.37M derived: sum of 2 quarters · filed 2023-02-28 | $65.19M derived: sum of 3 quarters · filed 2023-02-28 | $81.32M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $21.59M 10-Q · filed 2021-11-04 | $41.41M derived: sum of 2 quarters · filed 2021-11-04 | $57.54M 10-Q · filed 2021-11-04 | $74.91M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $19.82M 10-Q · filed 2021-08-04 | $35.95M 10-Q · filed 2021-08-04 | $53.32M derived: sum of 3 quarters · filed 2022-02-24 | $68.65M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $16.13M 10-Q · filed 2021-05-05 | $33.50M derived: sum of 2 quarters · filed 2022-02-24 | $48.83M derived: sum of 3 quarters · filed 2022-02-24 | $63.68M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $17.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $32.70M derived: sum of 2 quarters · filed 2022-02-24 | $47.55M derived: sum of 3 quarters · filed 2022-02-24 | $59.24M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $15.33M 10-Q · filed 2020-11-12 | $30.18M derived: sum of 2 quarters · filed 2020-11-12 | $41.87M 10-Q · filed 2020-11-12 | $48.31M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $14.85M 10-Q · filed 2020-08-12 | $26.54M 10-Q · filed 2020-08-12 | $32.99M derived: sum of 3 quarters · filed 2021-02-25 | $38.22M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $11.69M 10-Q · filed 2020-05-12 | $18.14M derived: sum of 2 quarters · filed 2021-02-25 | $23.36M derived: sum of 3 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $11.68M derived: sum of 2 quarters · filed 2021-02-25 | $18.49M 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $5.23M 10-Q · filed 2019-11-12 | $12.04M 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $4.66M 10-K · filed 2020-03-12 |